Clinical Trial Update: Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for Venetoclax in children with relapsed acute myeloid leukemia, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: PedAL BCU, LLC | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: RECRUITING